[1]LOUIS DN,PERRY A,REIFENBERGER G,et al.The 2016 World Health Organization classification of tumors of the central nervous system:a summary[J].Acta Neuropathol,2016,1316:803-820.
[2]OSTROM QT,GITTLEMAN H,LIAO P,et al.CBTRUS statistical report:primary brain and central nervous system tumors diagnosed in the United States in 2007-2011[J].Neuro Oncol,2014,Suppl 4(Suppl 4):iv1-63.
[3] LIU J,LI C,WANG Y,et al.Prognostic and predictive factors in elderly patients with glioblastoma:A single-center retrospective study[J].Front Aging Neurosci,2022,13:777962.
[4] ELSAKA R,KITAGWA JM,REFAAT T,et al.Impact of extended adjuvant temozolamide beyond 6 months in the management of glioblastoma patients[J].Am J Clin Oncol,2023,46(3):101-106.
[5] PAUN L,MOIRAGHI A,JANNELLI G,et al.From focused ultrasound tumor ablation to brain blood barrier opening for high grade glioma:A systematic review[J].Cancers (Basel),2021,13:5614.
[6] GU X,WAN G,CHEN N,et al.DGKz plays crucial roles in the proliferation and tumorigenicity of human glioblastoma[J].Int J Biol Sci,2019,15:1872-1881.
[7] GILLMAN R,FIELD MA,SCHMITZ U,et al.Identifying cancer driver genes in individual tumors[J].Comput Struct Biotechnol J,2023,21:5028-5038.
[8] MARUSYK A,JANISZEWSKA M,POLYAK K.Intratumor heterogeneity:TheRosetta stone of therapy resistance[J].Cancer Cell,2020,37:471-484.
[9] WANG H,CHENG Y,MAO C,et al.Emerging mechanisms and targeted therapy of ferroptosis in cancer[J].Mol Ther,2021,29:2185-2208.
[10] STOCKWELL BR,FRIEDMANN ANGELI JP,BAYIR H,et al.Ferroptosis:A regulated cell death nexus linking metabolism,redox biology,and disease[J].Cell,2017,171:273-285.
[11] VARYNSKYI B,SHICK JA.Hacking the lipidome:new ferroptosis strategies in cancer therapy[J].Biomedicines,2024,12(3):541.
[12] YANG WS,KIM KJ,GASCHLER MM,et al.Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis[J].Proc Natl Acad Sci USA,2016,113:E4966-4975.
[13] DIXON SJ.Ferroptosis:bug or feature[J].Immunol Rev,2017,277:150-157.
[14] LEMASTERS JJ.Evolution of voltage-dependent anion channel function:frommolecular sieve to governator to actuator of ferroptosis [J].Front Oncol,2017,7:303.
[15] IVANOV SD,SEMENOV AL,KOVAN'KO EG,et al.Effects of iron ionsand iron chelation on the efficiency of experimental radiotherapy of animals withgliomas[J].Bull Exp Biol Med,2015,158:800-803.
[16] SHIMADA K,SKOUTA R,KAPLAN A,et al.Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis[J].Nat Chem Biol,2016,12:497-503.
[17] ALIM I,CAULFIELD JT,CHEN Y,et al.Selenium drives a trans criptional adaptive program to block ferroptosis and treatstroke[J].Cell,2019,177:1262-1279.
[18] PUNZIANO C,TROMBETTI S,CESARO E,et al.Antioxidant systems as modulators of ferroptosis:focus on transcription factors[J].Antioxidants (Basel),2024,13(3):298.
[19]AZAM S,PARK JY,KIM IS,et al.Piperine and its metabolite's pharmacology in neurodegenerative and neurological diseases[J].Biomedicines,2022,10(1):154.
[20] ZHANG XS.Study on the mechanism of piperlongumine in iron death of gastric cancer cells[J].The Chinese Journal of Clinical Pharmacology,2020,36(10):1280-1283.
[21] YAMAGUCHIT Y.Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis[J].Int J Oncol,2018,52:1011-1012.
[22] LIU JM.Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation[J].Biovhemical and Biophysical Research Communications,2013,437:87-93.
[23]文远超,余云湖,付晓红,等.荜茇酰胺对胶质瘤细胞增殖的影响[J].中国公共卫生,2017,33(3):468-470.
WEN YC,YU YH,FU XH,et al.Impact of piperlongumine on glioma proliferation[J].Chinese Journal of Public Health,2017,33(3):468-470.
[24]BISHT S,MAO Y,EASWARAN H.Epigenetic dynamics of aging and cancer development:current concepts from studies mapping aging and cancer epigenomes[J].Curr Opin Oncol,2024,36(2):82-92.
[25] ZHANG XS.Study on the mechanism of piperlongumine in iron death of gastric cancer cells[J].The Chinese Journal of Clinical Pharmacology,2020,36(10):1280-1283.
[26] 王宁,康华丽,薛金慧,等.铁死亡相关基因TFRC在胃癌组织中的表达及其与化疗药物敏感性的关系[J].现代肿瘤医学,2023,31(22):4183-4189.
WANG Ning,KANG Huali,XUE Jinhui,et al.Expression of iron death related gene TFRC in gastric cancer tissue and its relationship with chemotherapy drug sensitivity[J].Modern Oncology,2023,31(22):4183-4189.
[27] ALEXIOU GA,GEROGIANNI P,V ARTHOLOMATOS E,et al.Deferiproneenhances temozolomide cytotoxicity in glioma cells[J].Cancer Invest,2016,10:489-495.
[28] RAMADOSS T,WEIMER DS,MAYROVITZ HN.Topical iron chelator therapy:current status and future prospects[J].Cureus,2023,15(10):e47720.
[29] LI Y,ZHANG J,ZHANG K,et al,Scutellaria barbata inhibits hepatocellular carcinoma tumorigenicity by inducing ferroptosis of hepatocellular carcinoma cells[J].Front Oncol,2022,12:693395.
[30] FORCINA GC,DIXON SJ.GPX4 at the crossroads of lipid homeostasis and ferroptosis[J].Proteomics,2019,19(18):e1800311.
[31]程峰,张庸,王祥,等.谷胱甘肽过氧化物酶GPX4在铁死亡中的作用与机制研究进展[J].现代肿瘤医学,2021,29(07):1254-1258.
CHENG Feng,ZHANG Yong,WANG Xiang,et al.Research progress on the role and mechanism of GPX4 in ferroptosis[J].Modern Oncology,2021,29(07):1254-1258.
[32]IMAI H,MATSUOKA M,KUMAGAI T,et al.Lipid peroxidation-dependent cell death regulated by GPx4 and ferroptosis[J].Curr Top Microbiol Immunol,2017,403:143-170.
[33]KONG N,CHEN X,FENG J,et al.Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1[J].Acta Pharm Sin B,2021,11:4045-4054.
[34]ZHANG S,XIN W,ANDERSON GJ,et al.Double-edge sword roles of iron in driving energy production versus instigating ferroptosis[J].Cell Death Dis,2022,13:40.
[35]JAKOBSEN S,NIELSEN CU.Exploring amino acid transporters as therapeutic targets for cancer:an examination of inhibitor structures,selectivity issues,and discovery approaches[J].Pharmaceutics,2024,16(2):197.
[36]DODSON M,CASTRO-PORTUGUEZ R,ZHANG DD.NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis[J].Redox Biol,2019,23:101107.
[37] 高洁,杜润蕾.Keap1-NRF2在癌症中的激活与失调机制[J].现代肿瘤医学,2021,29(22):4068-4072.
GAO Jie,DU Runlei.Keap1-NRF2 activation and dysregulation mechanisms in cancer[J].Modern Oncology,2021,29(22):4068-4072.
[38] DONG M,LU J,XUE H,et al.Anthocyanins from lycium ruthenicum murray mitigate cadmium-induced oxidative stress and testicular toxicity by activating the Keap1/Nrf2 signaling pathway[J].Pharmaceuticals (Basel),2024,17(3):322.
[39] AWUAH WA,TOUFIK AR,YARLAGADDA R,et al.Exploring the role of Nrf2 signaling in glioblastoma multiforme[J].Discov Oncol,2022,13(1):94.
[40] ANDRES CMC,PEREZDELA LASTRA JM,BUSTAMANTE MUNGUIRA E,et al.Electrophilic compounds in the human diet and their role in the induction of the transcription factor NRF2[J].Int J Mol Sci,2024,25(6):3521.
[41] PASINI D,DI CROCE L.Emerging roles for polycomb proteins in cancer[J].Curr Opin Genet Dev,2016,36:50-58.
[42]WM FAN T,ISLAM JMM,HIGASHI RM,et al.Metabolic reprogramming driven by EZH2 inhibition depends on cell-matrix interactions[J].J Biol Chem,2024,300(1):105485.
[43]YIN X,YANG S,ZHANG M,et al.The role and prospect of JMJD3 in stemcells and cancer[J].Biomed Pharmacother,2019,118:109384.
[44] LIU GZ,XU XW,TAO SH,et al.HBx facilitates ferroptosis in acute liver failure via EZH2 mediated SLC7A11 suppression[J].J Biomed Sci,2021,28:67.
[45]LI JN,GAO W,ZHAO ZH,et al.Ginsenoside Rg1 reduced microglial activation and mitochondrial dysfunction to alleviate depression-like behaviour via the GAS5/EZH2/SOCS3/NRF2 axis[J].Molecular Neurobiology,2022,59:2855-2873.
[46] BEZERRA DP,PESSOA C,DE MORAES MO,et al,Overview of the therapeutic potential of piplartine (piperlongumine)[J].European Journal of Pharmaceutical Sciences,2013,48(3):453-463.